Tom Van Ginneken
Head of Business Development

Wirthwein Medical

Is this your profile?

About

Tom Van Ginneken, Head of Business Development, currently leads the business development activities at Wirthwein Medical, focusing on innovative solutions for pharmaceutical primary packaging. With over 20 years
of experience in the pharma and healthcare industry, he has spent the majority of his career developing syringe systems and, over the last decade, has been a key driver in the adoption of COC syringes for a broadening range of applications. Mr Van Ginneken holds a degree in Chemical Engineering from the University of Antwerp (Belgium) and an MBA from the University of St Gallen (Switzerland).

Contributions

PREFILLED SYRINGES

HOW COC SYRINGES ARE SHAPING THE FUTURE OF INJECTABLE DRUG DELIVERY

Tom Van Ginneken explores the advantages of cyclo-olefin copolymer syringes, including where they outperform glass, which applications benefit most and why many common objections are outdated or debunked by current data, market adoption and technological advances.

More contributions

PREFILLED SYRINGES

DELIVERY SOLUTIONS FOR DEEP-COLD DRUGS

Tom Van Ginneken considers how the growing pipeline of molecules that require cold storage has highlighted the need for better drug containment and delivery methods and highlights the potential SCHOTT TOPPAC^® freeze syringes offer as a potential solution.

PREFILLED SYRINGES

INNOVATIVE SOLUTIONS FOR PACKAGING BIOLOGICS

Florence Buscke, Nicolas Eon and Tom Van Ginneken outline SCHOTT’s offering across both glass and polymer primary containers for pharmaceuticals, emphasising their advantages in the rapidly growing biologics market.

TOM VAN GINNEKEN, SCHOTT

Tom Van Ginneken discusses the advantages of polymers as a material for primary pharmaceutical packaging and how the company supports pharma manufacturers with engineering capabilities for individualised containers and rapid prototyping.

Top